Clinomics Inc. (KOSDAQ: 352770)

Clinomics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	1,707	11,046	8,599	16,836	12,833	2,572
Short-Term Investments	1,491	2,101	9,196	22,147	17,101	14,740
Trading Asset Securities	-	-	-	4,961	-	-
Cash & Short-Term Investments	3,198	13,147	17,794	43,944	29,933	17,312
Cash Growth	-91.36%	-26.12%	-59.51%	46.81%	72.90%	457.31%
Accounts Receivable	1,091	1,106	29,580	27,097	1,586	1,132
Other Receivables	500.37	274.8	377.11	265.85	261.52	423.99
Receivables	4,055	1,839	30,622	28,091	1,856	1,582
Inventory	2,209	2,386	2,786	1,615	675.86	823.54
Prepaid Expenses	65.75	79.76	52.34	67.37	191.88	162.29
Other Current Assets	6,609	747.97	839.93	707.22	568.01	516.29
Total Current Assets	16,136	18,199	52,095	74,425	33,225	20,397
Property, Plant & Equipment	45,235	28,284	28,522	19,957	9,467	6,211
Long-Term Investments	13,308	11,268	13,921	6,934	97.04	-0
Goodwill	1,718	3,423	-	-	-	-
Other Intangible Assets	4,052	2,532	809.33	594.95	365.83	272.13
Long-Term Accounts Receivable	10,653	9,817	-	-	-	-
Other Long-Term Assets	1,361	448.47	1,276	676.98	605.17	56.28
Total Assets	94,204	74,484	97,104	102,587	43,760	26,936
Accounts Payable	789.06	509.9	53.66	73.79	214.62	69.32
Accrued Expenses	472.17	304.27	458.96	625.71	189.83	163.56
Short-Term Debt	24,694	9,316	13,379	13,297	-	-
Current Portion of Long-Term Debt	2,238	761.37	38.45	-	67.8	347.8
Current Portion of Leases	1,106	803.42	814.1	711.42	254.44	142.9
Current Income Taxes Payable	3,381	3,209	5,648	8,266	-	-
Other Current Liabilities	18,496	5,467	13,143	16,248	1,807	1,535
Total Current Liabilities	51,175	20,371	33,536	39,222	2,533	2,259
Long-Term Debt	1,700	7,689	3,888	145.87	203.4	18,615
Long-Term Leases	2,116	1,512	2,217	2,652	292.04	141.2
Long-Term Deferred Tax Liabilities	313.07	330.96	5.31	476.11	-	-
Other Long-Term Liabilities	699.94	627.11	403.21	297.76	123.38	97.6
Total Liabilities	56,826	31,576	40,762	43,974	3,841	21,886
Common Stock	3,889	3,198	1,362	1,347	1,332	907.09
Additional Paid-In Capital	101,481	90,122	64,902	62,369	60,771	15,076
Retained Earnings	-72,415	-58,005	-15,834	-7,318	-23,286	-10,432
Treasury Stock	-904.88	-904.88	-909	-909	-909	-909
Comprehensive Income & Other	5,101	4,223	3,416	3,125	2,012	407.53
Total Common Equity	37,151	38,632	52,938	58,614	39,920	5,050
Minority Interest	227.11	364.59	258.59	-	-	-
Shareholders' Equity	37,378	42,908	56,342	58,614	39,920	5,050
Total Liabilities & Equity	94,204	74,484	97,104	102,587	43,760	26,936
Total Debt	31,853	20,082	20,337	16,807	817.68	19,247
Net Cash (Debt)	-28,655	-6,935	-2,543	27,138	29,115	-1,934
Net Cash Growth	-	-	-	-6.79%	-	-
Net Cash Per Share	-845.76	-257.83	-106.82	1264.88	1929.06	-151.68
Filing Date Shares Outstanding	38.45	31.97	19.96	19.73	19.5	13.61
Total Common Shares Outstanding	38.45	31.97	19.96	19.73	19.5	13.61
Working Capital	-35,039	-2,172	18,559	35,203	30,692	18,138
Book Value Per Share	966.28	1208.35	2652.65	2970.54	2047.24	371.13
Tangible Book Value	31,381	32,677	52,129	58,019	39,554	4,778
Tangible Book Value Per Share	816.20	1022.09	2612.10	2940.39	2028.48	351.13
Land	30,134	12,232	10,147	5,494	960.57	988.07
Buildings	10,427	11,669	10,293	3,454	2,305	2,325
Machinery	17,908	16,437	11,106	9,775	6,931	3,424
Construction In Progress	39.48	-	427.53	1,640	400	68

Source: S&P Capital IQ. Standard template. Financial Sources.